Navigation Links
Caltech scientists show how ubiquitin chains are added to cell-cycle proteins
Date:12/2/2009

e its slowest step even slower," he says. "If we can slow down ubiquitin ligases enough, they may become too slow to get their job doneto build chainsin the time available to them to do so. Being able to develop drugs to block their function would open up a new frontier in medicine."

"We were able to invent HIV therapeutics because we understand how reverse transcriptase works," adds Pierce. "The same applies here. We need to understand how these enzymes work if we're ever going to be able to target them with therapeutics."


'/>"/>

Contact: Lori Oliwenstein
lorio@caltech.edu
626-395-3631
California Institute of Technology
Source:Eurekalert  

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Caltech chemists say antibody surrogates are just a click away
2. Caltech engineers build first-ever multi-input plug-and-play synthetic RNA device
3. Vanderbilt scientists report first effective medical therapy for rare stomach disorder
4. Childrens Hospital Oakland scientists discover soy component may be key to fighting colon cancer
5. BIDMC scientists awarded grants from Michael J. Fox Foundation for Parkinsons research
6. Scientists find molecular trigger that helps prevent aging and disease
7. Chinese Scientists Develop Database on the Liver
8. Scientists Grow New Penile Tissue in the Lab
9. Social Network for Translational Scientists Launched
10. Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents, According to Scientists at the Feinstein Institute for Medical Research and Zucker Hillside Hospital
11. Physical scientists at Arizona State University will apply laws of physics in cancer fight
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Caltech scientists show how ubiquitin chains are added to cell-cycle proteins
(Date:6/20/2013)... 2013 Dr. Ramtin Kassir is ... Jersey and NYC and a top cosmetic ... his philosophy is to provide individualized care for a broad ... laser-lifts. The surgeon is partnering with the new and emerging ... Co for its specialized needs. , "We are partnering with ...
(Date:6/20/2013)... Footwear etc. is pleased to announce the relaunch of ... new styles and colors for the spring. This line includes ... in the U.S. The relaunch is expected to be incredibly ... MBT shoes feature a unique rocker sole bottom that emulates ... outstanding shock absorption, and helps produce improved posture. Customers have ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 David Icke, the ... global TV and Radio station. , Fresh from the ... David Icke is getting ready to launch ‘The Peoples Voice’ ... This station is a fantastic opportunity for journalists to cover ... from all areas of the globe. , Because this ...
(Date:6/20/2013)... City, UT (PRWEB) June 20, 2013 ... assurance solution that guides users through a HIPAA Security ... The new website launched today extends the reach of ... of HIPAA Security Officers, HIPAA Privacy Officers, security professionals, ... security, privacy, consulting, measures, processes, policies and procedures. ...
(Date:6/19/2013)... Everyone is looking for ways to improve general health. Sublime ... It is called Skin Brushing . Skin Brushing can be ... - to improve health and skin quality. It is fun ... Skin Brushing improves general health because:, , it ... to drain toxins , it clears skins of dead ...
Breaking Medicine News(10 mins):Health News:Celebrity Plastic Surgeon Dr. Kassir Teams Up With X Factor Selling Systems to Enhance Patient Experience 2Health News:Footwear etc. Announces New MBT Shoes for Spring/Summer 2Health News:Modern Compliance Solutions Launches a New Web Site Promoting the Industry-Proven, Web-Based HIPAA One Security Solution 2Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2
... ... approval of its biologics license application (BLA) for the first 15 monoclonal antibodies in its ... an exclusive agreement with the MED Alliance Group, Inc. (MAGI) to serve as its distributor ... ...
... DALLAS, Oct. 28 Parkland Health & Hospital ... limited English speaking patients by expanding its language ... Phones in patient rooms and other locations throughout ... from Language Line Services, the leading interpretation and ...
... Inc., a subsidiary of Eisai Inc., announced today that ... Ortho Biotech Inc. for development and commercialization of an ... solid tumors. , Under the terms of ... license for the development, manufacture and sale of the ...
... 28 /PRNewswire-Asia/ -- Winner Medical Group Inc.,(AMEX: WWIN ... and,the largest exporter by volume in the medical dressing ... (Shenzhen) Co., Ltd., or,"Winner Shenzhen", won a Contribution in ... The winner of the Contribution in ...
... Connectyx Technologies Holdings Group Inc. (Pink Sheets: CTYX), announced ... revolutionary tool for the management of medical, health and lifestyle ... internet based, data storage and transfer platform that allows a ... features secure storage and access to data from a variety ...
... LONDON, October 28 Parents looking to ... advised to buy,BornFree(TM), the world,s leading brand for baby ... (BPA), which is now available,across the UK. , ... BPA leach into food or beverages,stored in polycarbonate containers, ...
Cached Medicine News:Health News:Quotient Biodiagnostics Signs MED Alliance Group, Inc. as Exclusive Distributor in Midwest for Line of Transfusion Diagnostics 2Health News:Quotient Biodiagnostics Signs MED Alliance Group, Inc. as Exclusive Distributor in Midwest for Line of Transfusion Diagnostics 3Health News:Parkland Health & Hospital System Expands Language Access with Language Line(R) Phones in Every Patient Room 2Health News:Parkland Health & Hospital System Expands Language Access with Language Line(R) Phones in Every Patient Room 3Health News:Morphotek(R), Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody 2Health News:Winner Medical's Subsidiary Won Contribution in Chinese Nonwovens and Industrial Textiles Industry Award 2Health News:Winner Medical's Subsidiary Won Contribution in Chinese Nonwovens and Industrial Textiles Industry Award 3Health News:Connectyx Announces the MedFlash Personal Health Manager 2Health News:Connectyx Announces the MedFlash Personal Health Manager 3Health News:BornFree Baby Bottles Borne Into Britain 2
(Date:6/19/2013)... 2013  Decision Resources, one of the world,s ... healthcare issues, finds that, for the treatment of ... European rheumatologists cite a therapy,s induction of remission ... their prescribing decisions. Over 60 percent and 70 ... the percentage of patients achieving remission at six ...
(Date:6/19/2013)... , June 19, 2013 BD Biosciences, a segment ... ), a leading global medical technology company, today announced the ... the latest in its line of high-performance research flow cytometers. ... high-performance multicolor analysis with the most compact footprint in its ... and a height of 30" (76.2 cm). Recognizing that space ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- ... a new specialty pharmaceutical company dedicated to ... innovative injectable and sustained release drug therapies ... medical needs, today announced the acquisition of ... Technology®) platform and associated product pipeline. Acquisition ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
... Unprecedented amount of research reflects depth and breadth of, collaboration with investigators ... ... highlight impact of Zometa(R), the leading IV, bisphosphonate, on relapse rate of patients ... oral once-daily continuous, inhibitor of mTOR, including first results of RECORD-1 study in ...
... identify the, lipid core (fatty) coronary plaques of interest ... ... 15 InfraReDx, Inc. today,announced that physicians at Beaumont Hospital ... System in a patient,undergoing a cardiac catheterization. This is the ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4
... Sports Medicine™ POLYSORB™ Soft Tissue Anchor 3 mm ... soft tissue to bone using sutures. The resorbable ... in the bone, and is used to attach ... a resorbable copolymer, derived from glycolide and lactide ...
... USS Sports Medicine™ POLYSORB™ Soft Tissue Anchor 2 ... attach soft tissue to bone using sutures. The ... hole in the bone, and is used to ... made of a resorbable copolymer, derived from glycolide ...
Sutureless Harpoon Tip...
... type of anchor is generally utilized when a ... into the bone. Unlike other anchors that require ... does not have that limitation. The only instrument ... a mallet. The 4.4mm Stainless Steel Anchor is ...
Medicine Products: